透析中的酸盐结合剂:对患者的服药坚持和药物负担的横截面研究
Brunelle Bruna Scavello Coelho Ferezin1, Luiza Karla Ramos Pereira de Araújo2, Carolina Marquez Lima2
1Universidade Nove de Julho, São Paulo, SP, Brazil.
Jornal brasileiro de nefrologia
|January 21, 2025
概括
慢性病患者的酸盐结合剂粘附率较低,特别是血液透析的妇女. 需要进行干预措施来改善药物坚持和患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 酸盐结合剂对于治疗慢性病 (CKD) 患者进行透析的高酸血症至关重要.
- 关于酸盐结合剂粘附性的数据有限,特别是比较不同的透析方式.
研究的目的:
- 在透析患者中调查与酸盐结合剂粘附相关的因素.
- 为了比较血液透析和腹膜透析模式之间的坚持率.
主要方法:
- 评估的坚持是报告给处方药的比例,不坚持被定义为>20%的偏差.
- 分析了137名透析患者的人口统计,临床和实验室数据.
- 利用后勤回归来识别不遵守的独立预测因素.
主要成果:
- 总体粘附性因粘合剂类型 (碳酸100% ,胺68.4%) 有显著差异.
- 女性性别和血液透析独立地与不坚持相关 (HR分别为3.30和4.55).
- 过酸性血症影响了36.4%的患者,其坚持与处方和服用药片数量相关.
结论:
- 对酸盐结合剂的坚持是透析患者的一个重要问题,需要有针对性的干预措施.
- 需要进一步的研究来确定酸盐结合剂粘附对患者结局的影响.
相关概念视频
Drug Distribution: Tissue Binding
2.5K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.5K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
34
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
34
Drug Distribution: Plasma Protein Binding
4.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
4.8K
Renal Failure: Dose Adjustments
61
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
61
Dialysis
256
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
256
Factors Affecting Protein-Drug Binding: Protein-Related Factors
116
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
116


